News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
AusperBio Reports Significant Progress in Advancing AHB-137 Clinical Development
Friday, July 05, 2024AusperBio Therapeutics Inc and Ausper Biopharma Co Ltd a biotechnology firm specializing in oligonucleotide therapies have made significant strides in developing AHB their lead candidate for treating chronic hepatitis B CHB infection
Pentixapharm Completes Acquisition of Glycotope's Target Discovery Division
Thursday, July 04, 2024Pentixapharm AG a clinicalstage biotech company specializing in developing targeted radiopharmaceuticals for treating cancer has acquired Glycotope GmbHs target discovery business effective July st This acquisition includes a portfolio of preclinical...
Owkin Expands AI-Biotech Presence into Germany, Austria, and Switzerland to Enhance Research Acceleration
Wednesday, July 03, 2024Owkin a prominent AIbiotech firm has expanded into the DACH region by forming partnerships with nine leading institutions These include Charit Universittsmedizin Berlin
Radionetics Oncology and Lilly Enter Strategic Agreement
Tuesday, July 02, 2024Radionetics Oncology a biotechnology company focused on developing innovative small molecule radiopharmaceuticals for targeting G proteincoupled receptors to treat solid tumors has announced a strategic partnership with Eli Lilly and Company The coll...
Signet Therapeutics receives FDA IND approval for the first targeted therapy designed for Diffuse Gastric Cancer
Tuesday, July 02, 2024Signet Therapeutics a biotech company specializing in organoid disease models and AI for targeted cancer therapy announced FDA approval of its Investigational New Drug application for sigx
Taurx Pharmaceuticals Has Applied for Marketing Authorisation in the UK for HMTM as an Alzheimer's Treatment
Monday, July 01, 2024TauRx Pharmaceuticals Ltd has submitted a UK Marketing Authorisation Application for hydromethylthionine mesylate targeting mild cognitive impairment and mild
Waypoint Bio Raises $14.5 Million to Enhance Drug Discovery Through in vivo Spatial Pooled Screening Technology
Saturday, June 29, 2024Waypoint Bio a biotechnology company has secured million in seed funding led by Hummingbird Ventures with participation from Recode Ventures and Fifty Years The company focuses on developing
AQEMIA and Servier Reach Milestone in Immuno-Oncology Targeting Challenging Conditions
Saturday, June 29, 2024AQEMIA a leader in AIdriven drug discovery has achieved a significant research milestone in collaboration with Servier an international pharmaceutical company targeting an unmanageable
Bayer and Rad AI Collaborate to Advance Radiology through AI
Friday, June 28, 2024Bayer and Rad AI have announced a new partnership at the SIIM conference focusing on integrating Rad AIs AIdriven radiology operational solutions into Bayers Calantic Digital Solutions platform Rad AI provides advanced technologies like radiology spe...
ReCode Therapeutics Receives FDA Orphan Drug Designation for RCT1100 Targeting Primary Ciliary Dyskinesia
Friday, June 28, 2024ReCode Therapeutics announced today that the US Food and Drug Administration has granted Orphan Drug Designation to RCT for the treatment of primary ciliary dyskinesia This genetic disease
